See all COVID-19 research updates, including updated human-subjects research guidance and participant screening script, here.
Clinical Research Centers (CRCs) provide research infrastructure for investigators who conduct research with human subjects.
Investigations can include studies of normal and abnormal human function and studies of cause, progression and cure of diseases.
The Clinical Research Center is part of Penn State Clinical and Translational Science Institute’s clinical services function.
Clinical Research Centers are located at Penn State Health Milton S. Hershey Medical Center in Hershey and the Elmore Wing of the Clinical Research Center in University Park.
A Clinical Research Center Advisory Committee provides oversight and all protocols are approved by this committee before work begins. Institutional Review Board approval is also required.
For details about the Clinical Research Center in Hershey, email nurse manager Christine Capper at ccapper@pennstatehealth.psu.edu.
For details about the Clinical Research Center in University Park, email nurse manager Cyndi Flanagan at chf117@psu.edu or Shaweta Gupta Singla, Clinical and Translational Science Institute associate administrative director, at sug450@psu.edu.
Jump to topic
Search
Meet the Clinical Research Center Team in Hershey
Application Process: Clinical Research Center in Hershey
To apply to use the Clinical Research Center, please complete the application form here.
For details, email crc@pennstatehealth.psu.edu.
Applications are due the 15th of each month for review the first Wednesday of the following month. Reviews are not done in January or July; investigators must plan accordingly.
Clinical Research Center Services in Hershey
The Clinical Research Center nursing staff members work in partnership with investigators throughout Penn State to implement and complete clinical research protocols.
Clinical Research Center nursing staff members are available 7:30 a.m. to 4:00 p.m. weekdays.
Penn State has biostatisticians, epidemiologists and methodologists with a diverse set of expertise located within several departments and centers in both Hershey and University Park. Biostatistics, Epidemiology and Research Design (BERD) consultations are offered through Penn State Clinical and Translational Science Institute and pool Penn State resources across campuses to offer training in biostatistical and epidemiological methodologies and assistance to investigators in study design, data management and analysis.
Clinical Research Center at Hershey has the Human Smoking and Addiction Laboratory, an observational study suite with two observation rooms.
One room is 124 square feet and the other is 91 square feet.
Each room includes one-way mirrored windows, reclining chair, desk and chair, special ventilation systems and audio/video capabilities. A blood draw area is also available directly outside room 2.
Ventilation
- Variable air volume supply and exhaust boxes that are programmed to create several environments
- Each observation room can be adjusted to simulate seven different air profiles via a wall dial
- The observer is in a neutral environment
- The overall airflow is isolated to create ideal testing environments for tobacco/smoking, vaping, aromatherapy and similar studies, and maintain the hospital non-smoking environment
Blood Draw Area
- Conveniently located outside observation room 2
- Space includes running water/sink
- Curtain for privacy
- Available to use for blood draws when staff can’t enter the room (i.e., intervention such as smoking or vaping that would expose staff to any health risks)
Audio/Video
- Ceiling-mounted high-definition cameras with pan/tilt/zoom ability
- Ceiling-mounted microphone
- Observation room speaker
- Four-output headphone amplifiers
- Professional headphones
- Push-to-talk intercom
- Touchscreen operation
- Video recording via computer
Clinical Research Center in Hershey manages Exercise Research Center, a separate facility located in Hershey Center for Applied Research off Bullfrog Valley Road. Use of this space follows the same approval process as using Clinical Research Center, as outlined on this page. Use of this space is billed fee-for-service.
Services offered
- Collection of vitals, including height, weight, waist, resting blood pressure and resting heart rate
- Seven-site skinfold test
- Resting ECG
- Biodex: Isokinetic dynamometer that measures maximal muscle strength on single joints in various planes of the body
- Bioelectrical impedance: Body composition measurements including total body fat, total body water, intracellular and extracellular fluid measurements
- Resting metabolic test: Measurements include VO2, RER, heart rate
- Exercise metabolic test: Can be performed on the treadmill, stationary bicycle or arm bicycle; measurements include VO2, RER, heart rate, ECG monitoring
- DXA scan
- Total body composition/densitometry (the same scan provides both analyses)
- AP spine
- Dual femur
- Forearm
- Lateral spine
- Lateral vertebral assessment
- Pulmonary function tests
- Maximal voluntary ventilation
- Maximal inspiratory pressure
- Maximal expiratory pressure
- DLCO
- Forced vital capacity
Investigator Responsibilities
The purpose of the Clinical Research Center is to promote and support patient-oriented research. Clinical Research Center personnel facilitate and document the collection of accurate and timely data to complete the research protocol and to administer the research support grants appropriately. The medical care of patients admitted to Penn State College of Medicine’s Clinical Research Center is the primary responsibility of the physician investigator. Since the Clinical Research Center provides services new to many investigators, the following investigator expectations may be beneficial.
After a Clinical Research Center protocol is approved, the principal investigator is responsible for several tasks, all listed in this section. Click each header for details.
Schedule an initiation meeting with Christine Capper, RN, Clinical Head Nurse for the Clinical Research Center.
She can be reached at 717-531-1642 or ccapper@pennstatehealth.psu.edu. All visits are scheduled through her or her designate.
Beyond the initial qualification screening of a potential participant, informed consent must be obtained before any procedures or further investigation can be done.
The principal investigator is responsible for obtaining consent directly.
If this responsibility is delegated to study personnel, the principal investigator ensures that they are fully qualified to explain the study, answer questions and evaluate the participant’s understanding of the study before having the participant sign the form.
Be sure the signature part of the consent form is consistent with the practice; e.g., if investigator signature is required, a named investigator takes the consent from the participant and signs it at that time.
Signature of “Person Obtaining Consent” may be used instead of “Investigator Signature”; qualification of the person obtaining consent is the responsibility of the investigator.
Identification of pools of potential participants and development of advertising is the responsibility of the investigator; this may include obtaining permission of other physicians to contact their patients.
Clinical Research Center personnel may be able to help with initial telephone screening, utilizing a question form developed by the investigator. The Clinical Research Center nurse coordinating the study may be involved in further screening of participants found appropriate for consideration in initial screening.
Selection of participants for inclusion in the study is the investigator’s responsibility.
Physician orders for medications and infusions must be written for each participant and, in certain studies, prescriptions must be written for dispensing by the pharmacy. The investigator or a co-investigator must be available in the building during infusions and at any other time required for special procedures, e.g., during observation following investigative vaccinations.
The Clinical Research Center medical record serves as the primary source document for all data reporting. The investigator and nurse must agree on their respective responsibilities for collecting and recording data for each study and must develop a system to facilitate that process. The nurse will review data (laboratory reports, etc.) for safety and efficacy and refer to the principal investigator as needed. The investigator is responsible for the accuracy of reported data.
The principal investigator is responsible for data management and analysis. The Clinical Research Center provides consultation from its informatics core director and the biostatistician on methods of data management, transfer and analysis.
In addition, four computers and a laser printer are available for the use of principal investigators and their designated staff to use on a first-come, first-served basis; training is available from the informatics core director on the use of these systems. Data entry is available contractually.
The informatics core director is responsible for maintaining integrity, security and backups of the data with input from the principal investigator. The informatics core director is available for training and troubleshooting in the use of Clinical Research Center computer systems for data management and analysis.
Actual analysis is the responsibility of the investigator. The principal investigator is responsible for establishing an analysis schema with assistance from the biostatistician and informatics core director.
The investigator must provide budget and fund number.
In addition to the initiation meeting with the clinical head nurse that is required before starting a study, regular meetings of the study team are strongly recommended to maintain timely and complete communication and study progress.
The investigator is responsible for being available or for communicating who is providing medical coverage in their absence; the investigator is responsible for study-related instruction of covering physician(s).
The Clinical Research Center is part of Penn State Clinical and Translational Science Institute. All publications from research supported in any way by the Clinical Research Center must cite Institute support.
All staff providing support to a protocol in the Clinical Research Center must have adequate training. This includes human subjects protection training, institutional safety training and protocol-specific procedural training.
It is the responsibility of the investigator or their designate to provide the Clinical Research Center with documentation that the human subjects protection training and the safety training have been successfully completed before a staff member works in the center.
Individuals working in the Clinical Research Center must have training credentials from a reliable source (RN license, phlebotomy certification, LPN license, etc.) or be trained by center staff.
Recognizing the need of the investigator’s staff to assist with procedures of blood drawing, phlebotomy, IV care, sample processing and collection of vital signs, and the expertise of the CRC staff in these skills, Clinical Research Center staff will provide training.
A completed, signed checklist for training must be on file before a staff member works in the Clinical Research Center.
All newly trained staff will have an experienced staff member from the investigator’s staff available in the Clinical Research Center during their first solo performance of the task.
Clinical Research Center Scheduling in Hershey
Patients must be scheduled at least one day in advance. Although email or fax requests are preferred, verbal requests may also be made. In any event, it is essential that the clinical investigator or their staff receive confirmation from the Clinical Research Center staff.
The CLinical Research Center expects the investigator or their staff to meet the patient at the time of the appointment.
In the event that an investigator or their staff do not meet the patient, center staff will call the investigator and/or staff.
The maximum delay that the Clinical Research Center can accept to start an appointment is 30 minutes.
If an investigator and/or staff are not in the center within 30 minutes, the CRC staff will advise the patient that it is their own decision as to whether they stay or leave.
In the event that three instances of a 30-minute or longer wait occur for a given protocol, the investigator will be informed that they will no longer be able to use the Clinical Research Center for that protocol.
In the event a patient/volunteer arrives at the Clinical Research Center for an unscheduled visit and the protocol and coordinator can be determined, the following process will occur. (Of necessity, when a patient/volunteer arrives at the center for an unscheduled visit and none of the pertinent information – protocol, coordinator or principal investigator – can be determined, the patient/volunteer will be turned away).
First Instance
- The coordinator will be notified by the Clinical Research Center clinical head nurse or their designate of the patient’s presence.
- The patient/volunteer will be accommodated as promptly as possible with a room.
- The center’s clinical head nurse will notify the PI via email of the occurrence and include a copy of the scheduling policy for unscheduled visits. The email will be copied to the study coordinator and the Clinical Research Center’s research subject advocate.
Second Instance
- The coordinator will be notified by the Clinical Research Center clinical head nurse or their designate of the patient’s presence.
- The patient/volunteer will be accommodated as promptly as possible with a room.
- The research subject advocate will notify the principal investigator and copy the clinical head nurse and study coordinator of the repeat offense. A copy of the scheduling policy and the policy for unscheduled visits will be included.
Third Instance
-
- The coordinator will be notified by the Clinical Research Center clinical head nurse or their designate of the patient’s presence.
- The patient/volunteer will be accommodated as promptly as possible with a room.
The research subject advocate will notify the principal investigator’s department chair of the incident including the fact that this is a repeated action. The chair will receive a copy of the scheduling policy and the policy for unscheduled visits. The principal investigator, Clinical Research Center clinical head nurse, study coordinator and Clinical Research Center program director will be copied on the correspondence.
Fourth Instance
- The coordinator will be notified by the Clinical Research Center clinical head nurse or their designate of the patient’s presence.
- The patient/volunteer will be accommodated as promptly as possible with a room.
- The research subject advocate will notify the principal investigator’s department chair that a fourth instance of an unscheduled visit has occurred. This notification will include the suspension of all scheduling privileges for this principal investigator and coordinator(s) combination for a period of three months. Copies of the notification will be sent to the principal investigator, the study coordinator, the Clinical Research Center research subject advocate, the Vice Dean for Research and Graduate Studies and the Clinical Research Center clinical head nurse.
Fifth instance during or after the suspension
- The coordinator will be notified by the Clinical Research Center clinical head nurse or their designate of the patient’s presence.
- The patient/volunteer will be accommodated as promptly as possible with a room.
- The Clinical Research Center program director will notify the principal investigator’s department chair that a fifth instance of an unscheduled visit has occurred. This notification will include the termination of use of Clinical Research Center resources for this principal investigator and coordinator(s) combination. No future protocols will be accepted for this investigator and coordinator(s) combination. Copies of the notification will be sent to the principal investigator, the study coordinator, the Clinical Research Center research subject advocate, the Vice Dean for Research and Graduate Studies and the Clinical Research Center clinical head nurse.
Future unscheduled visits will not be accommodated. If a patient arrives for an unscheduled visit, the principal investigator will be paged and expected to meet the patient and escort them to an appropriate place for the visit to take place, or to reschedule the visit at the patient’s convenience.
Resources
The work in the Clinical Research Center is guided by several agencies and regulations. These include:
- Institutional Review Board (IRB) and Human Subjects Protection Office (HSPO)
- CRC guidelines
- The Joint Commission
- Standards for Privacy of Individually Identifiable Health Information (internal access only; login required)
- Clinical Trials Office (internal access only; login required)
- College of Health and Human Development
- College of Medicine Core Facilities
- College of Medicine Research
- Harrell Health Sciences Library
- Penn State Children’s Hospital
- Penn State Health Milton S. Hershey Medical Center
- Penn State Cancer Institute
- Penn State Clinical and Translational Science Institute
- Penn State College of Medicine
- Penn State
- StudyFinder
- University Park Clinical Research Center